USPH - NYSE

U.S. Physical Therapy, Inc.

USPH·NYSE

$61.87

-1.0%

HealthcareMedical - Care Facilities

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$941.59M

EPS1.4200

P/E Ratio43.57

Earnings Date08/05/2026

1.20B

Assets

3Y+40.0%

5Y+103.0%

10Y+243.0%

433.81M

Total Liabilities

3Y+16.0%

5Y+135.0%

10Y+365.0%

769.74M

Total Equity

3Y+59.0%

5Y+88.0%

10Y+198.0%

U.S. Physical Therapy, Inc. Funding & Solvency Profile

USPH · NYSE

Current Assets

Cash & Cash Equivalents35.57M

Net Receivables64.25M

Inventory0.00

Other Current Assets40.17M

Total Current Assets140 M

Non-Current Assets

Property, Plant & Equipment271.07M

Goodwill & Intangible Assets865.25M

Long-Term Investments12.28M

Other Non-Current Assets-84.58M

Total Non-Current Assets199 M

Total Assets

1.20B

Financial Health Analysis

Current Ratio

1.01x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

0.56x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

950 K

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

12% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

U.S. Physical Therapy, Inc. Balance Sheet

USPH • NYSE

U.S. Physical Therapy, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	35.6M	41.4M	152.8M	31.6M	28.6M	32.9M	23.5M	23.4M	21.9M	20M	15.8M	14.3M	12.9M	11.7M	10M	9.2M	6.4M	10.1M	8M	11M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	500K
Cash & Short-Term Investments	35.6M	41.4M	152.8M	31.6M	28.6M	32.9M	23.5M	23.4M	21.9M	20M	15.8M	14.3M	12.9M	11.7M	10M	9.2M	6.4M	10.1M	8M	11.5M
Net Receivables	64.2M	85.7M	51.9M	68.6M	62.4M	50.9M	56.1M	51.5M	50.4M	41.5M	38.6M	34.6M	32.7M	27.7M	29.9M	26.4M	23.6M	26.8M	26.7M	22.3M
Accounts Receivables	64.2M	59M	51.9M	68.6M	46.3M	41.9M	46.2M	44.8M	44.7M	38.8M	36.2M	32.9M	30.8M	26M	28.3M	26.4M	23.6M	26.8M	26.7M	22.3M
Other Receivables	0.0	26.6M	0.0	0.0	16.1M	9M	9.8M	6.7M	5.7M	2.6M	2.6M	1.7M	2M	2.2M	2.5M	0.0	0.0	0.0	0.0	0.0
Other Current Assets	40.2M	10.6M	28.7M	11.1M	4.2M	3.8M	5.8M	11.1M	10.4M	7.1M	8.2M	7.7M	5.9M	7.7M	7.4M	3.7M	3M	1.9M	1.3M	2.3M
Total Current Assets	140M	137.6M	233.4M	111.3M	95.2M	87.6M	85.4M	79.2M	77.1M	66M	60.2M	54.9M	49.7M	45.3M	45.7M	39.3M	32.8M	38.7M	36M	36M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	271.1M	166.1M	129.5M	127.8M	119.4M	103.3M	103.7M	20.2M	20.4M	19.2M	16.7M	15.8M	15M	13M	13.2M	13.9M	14.3M	15.8M	16.8M	13.4M
Goodwill	692.4M	667.2M	509.6M	494.1M	434.7M	345.6M	317.7M	293.5M	271.3M	226.8M	171.5M	147.9M	144M	100.2M	92.8M	79.4M	57.2M	55.9M	37.7M	21M
Intangible Assets	172.9M	179.3M	109.7M	108.8M	86.4M	56.3M	52.6M	48.8M	49M	38.1M	30.3M	24.9M	14.5M	12.1M	9.6M	7.3M	6M	6.5M	3.9M	0.0
Goodwill & Intangible Assets	865.3M	846.5M	619.3M	602.9M	521.1M	401.9M	370.3M	342.4M	320.3M	264.9M	201.8M	172.8M	158.4M	112.3M	102.4M	86.7M	63.2M	62.3M	41.6M	21M
Long-Term Investments	12.3M	12.2M	12.3M	12.1M	12.2M	0.0	0.0	-2.5M	-2.1M	-2.5M	-2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5M	2.1M	2.5M	2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	-84.6M	5.2M	2.8M	4.1M	1.6M	1.5M	1.5M	1.4M	1.2M	1.2M	1.2M	1.1M	1.1M	1M	2M	922K	869K	1.3M	1.8M	1.1M
Total Non-Current Assets	1.1B	1B	763.9M	746.9M	654.3M	506.7M	475.5M	364M	341.9M	285.3M	219.7M	189.7M	174.5M	126.4M	117.6M	101.6M	78.4M	79.5M	60.2M	35.5M
Total Assets	1.2B	1.2B	997.2M	858.2M	749.4M	594.4M	560.8M	443.2M	419M	351.2M	279.9M	244.6M	224.1M	171.7M	163.3M	140.9M	111.3M	118.2M	96.3M	71.5M
LIABILITIES
CURRENT LIABILITIES
Total Payables	6.1M	20.3M	3.9M	15.5M	15.8M	31M	6.8M	2M	9.2M	1.6M	3.1M	3.6M	4.1M	3.2M	2.6M	1.2M	1.3M	1.5M	1.6M	1.6M
Accounts Payable	6.1M	5.9M	3.9M	6.5M	6.5M	1.3M	2.5M	2M	2.2M	1.6M	1.6M	1.8M	1.7M	1.7M	1.8M	1.2M	1.3M	1.5M	1.6M	1.6M
Other Payables	0.0	14.3M	0.0	9M	9.4M	29.7M	4.3M	0.0	7M	0.0	1.5M	1.8M	2.4M	1.5M	793K	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	45.2M	32.9M	28.4M	36.3M	30.1M	26.6M	21.7M	16.8M	10.6M	9.4M	15.4M	11.7M	9.8M	9.3M	9M	9.1M	6.5M	4.9M	2.2M
Short Term Debt	52M	11M	7.7M	7.9M	830K	4.9M	728K	1.4M	4M	1.2M	775K	883K	825K	459K	433K	250K	1M	1.4M	812K	562K
Capital Lease Obligations (Current)	0.0	39.8M	35.3M	33.7M	30.5M	27.5M	26.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	4.9M	1.4M	277K	2.7M	9.9M	0.0	0.0	2.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-175K	0.0	0.0	0.0
Other Current Liabilities	81M	0.0	22.5M	0.0	0.0	0.0	0.0	16.8M	9.5M	11.2M	5.7M	5.6M	6.6M	2.8M	4M	3.8M	3.3M	5.3M	4.2M	4.8M
Total Current Liabilities	139M	116.3M	102.2M	85.5M	83.5M	93.5M	60.6M	41.9M	39.6M	24.6M	19M	25.5M	23.2M	16.3M	16.3M	14.2M	14.6M	14.6M	11.4M	9.2M
NON-CURRENT LIABILITIES
Long Term Debt	263.2M	142.5M	139M	175.8M	117.6M	16.6M	50.4M	38.4M	56.7M	50.6M	48.3M	34.7M	40.7M	17.6M	23.8M	5.8M	400K	12.4M	8M	797K
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2M	2.1M	1.6M	-7.4M	0.0	0.0	0.0	941K	966K	1M	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	28.4M	29.5M	24.8M	21.3M	14.4M	7.8M	10.1M	9M	10.9M	15.7M	9.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	-107.4M	18.3M	2.4M	13M	7.3M	4.5M	141K	12M	13.7M	18.1M	1.4M	9.7M	5.2M	3.2M	623K	3.5M	3M	3.4M	1.8M	2.1M
Total Non-Current Liabilities	294.8M	292.1M	242.8M	288.1M	213.5M	90.9M	120.8M	50.4M	70.5M	68.7M	59M	44.5M	45.8M	20.7M	25.3M	10.2M	4.4M	15.8M	9.8M	2.9M
Capital Lease Obligations	110.6M	141.7M	111.9M	111.6M	104.7M	89.5M	86.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	433.8M	408.4M	345M	373.6M	297M	184.4M	181.4M	92.3M	110M	93.4M	78M	70M	69M	37.1M	41.7M	24.5M	19M	30.4M	21.2M	12.1M
SHAREHOLDERS' EQUITY
Treasury Stock	-37.2M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M	-31.6M
Common Stock	174K	172K	172K	152K	151K	151K	150K	149K	148K	147K	146K	145K	143K	141K	139K	139K	138K	142K	141K	137K
Additional Paid-In Capital	285.5M	290.3M	281.1M	110.3M	102.7M	95.6M	87.4M	80M	73.9M	68.7M	64.2M	43.6M	40.6M	37.5M	36.1M	45.6M	43.2M	43.6M	41.5M	36.3M
Retained Earnings	227.2M	227.3M	223.8M	232.9M	224.4M	212M	184.4M	167.4M	162.4M	150.3M	149M	134.2M	119.2M	111.3M	102.4M	89.9M	81.2M	69.4M	59.4M	50.7M
Accumulated Other Comprehensive Income/Loss	714K	2.8M	2.8M	4M	0.0	0.0	0.0	-64.2M	-60.5M	-56M	-53.3M	-49M	0.0	-44.2M	-42.3M	-39.2M	-36.6M	-33.2M	-29.3M	-25.6M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.2M	60.5M	0.0	53.3M	49M	0.0	0.0	42.3M	39.2M	36.6M	33.2M	29.3M	25.6M
Total Stockholders' Equity	476.4M	488.9M	476.2M	315.8M	295.6M	276.2M	240.3M	215.9M	204.9M	187.5M	162.8M	146.3M	128.3M	117.3M	107M	104M	87.4M	81.6M	69.4M	55.5M
Total Equity	769.7M	759M	652.2M	484.6M	452.4M	410M	379.5M	350.8M	309M	257.9M	202M	174.6M	155.1M	134.7M	121.6M	116.4M	92.2M	87.8M	75.1M	59.4M
Minority Interest	293.3M	270.1M	176M	168.8M	156.8M	133.8M	139.2M	134.9M	104.1M	70.3M	39.2M	28.3M	26.8M	17.3M	14.5M	12.4M	4.9M	6.2M	5.6M	3.9M
SUMMARY
Total Liabilities & Equity	1.2B	1.2B	997.2M	858.2M	749.4M	594.4M	560.8M	443.2M	419M	351.2M	279.9M	244.6M	224.1M	171.7M	163.3M	140.9M	111.3M	118.2M	96.3M	71.5M
Total Investments	12.3M	12.2M	12.3M	12.1M	12.2M	0.0	0.0	-2.5M	-2.1M	-2.5M	-2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	500K
Total Debt	425.7M	295.2M	258.6M	295.3M	223.1M	111M	137.8M	39.8M	60.8M	51.8M	49.1M	35.6M	41.5M	18M	24.2M	6M	1.4M	13.8M	8.8M	1.4M
Net Debt	390.2M	253.9M	105.8M	263.7M	194.5M	78.1M	114.3M	16.5M	38.8M	31.8M	33.3M	21.3M	28.6M	6.4M	14.2M	-3.2M	-5M	3.7M	795K	-9.6M
Shares Outstanding	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119	15,204,119

SEC Filings

USPH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 19, 2026	May 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 11, 2026	May 07, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 06, 2026	May 06, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 16, 2026	May 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 15, 2026	April 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 13, 2026	March 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 09, 2026	March 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 03, 2026	February 26, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 27, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 670 filings

Related Guides

Blog Categories

Continue your USPH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.